Musaddiq Khan

Musaddiq Khan has a strong background in the pharmaceutical industry with a focus on clinical operations and study management. Musaddiq is currently serving as the Vice President, DCT Solutions - Therapeutic Area Solutions Leader at Medable, Inc, where they lead the development of protocol, pipeline, and therapeutic area-focused DCT strategies. Musaddiq is also responsible for assessing and evaluating ecosystem partners, external subject matter experts, and key opinion leaders to support best-in-class solution sets.

Before joining Medable, Inc, Musaddiq Khan worked as the Director of Clinical Program Operations at Eli Lilly and Company. In this role, they managed a team of consultants and project managers, aligning the operational strategy of Clinical Pharmacology with program goals. Musaddiq also played a key role in shaping development plans and seeking continuous improvement opportunities from internal and external sources.

Prior to that, Musaddiq Khan held positions at AstraZeneca, where they served as an Associate Director in both the Clinical Operations and Alliances Strategy and Study Management departments. In these roles, they developed and oversaw preferred partner alliance relationships, managed existing relationships, and identified new opportunities. Musaddiq also provided technical leadership, training, and process improvement to implement clinical operations strategy. Additionally, as part of the Oncology Translational Medicine Unit, they led global, cross-functional teams in the planning and delivery of clinical studies and programs in solid tumor drug development.

Musaddiq Khan's experience also includes roles at Retroscreen Virology as Associate Director of Client Delivery and Project Director, where they oversaw successful project delivery, engaged with clients, and managed study design, budget, contracts, and scope. Musaddiq also worked at Roche as a pRED Clinical Study Leader, leading the planning, coordination, and direction of study management teams.

Earlier in their career, Musaddiq Khan worked as a Project Manager at PAREXEL, where they were responsible for managing international programs across various study designs. Musaddiq also gained experience as a Clinical Project Manager at Vitalograph.

Overall, Musaddiq Khan has demonstrated expertise in strategic planning, project management, process improvement, and alliance relationships within the pharmaceutical industry.

Musaddiq Khan completed their Master of Business Administration (MBA) degree at the University of Cambridge from 2016 to 2018. Prior to that, they studied at The University of Sheffield from 2005 to 2007. Musaddiq also obtained an MSc in Translational Medicine from Cranfield University in 2003 and a BSc (Hons.) in Clinical Sciences from King's College London from 2000 to 2003. Besides their formal education, Musaddiq Khan obtained a certification in Foundations of Decentralized Clinical Trials from Medable, Inc in July 2021. Musaddiq Khan also attended King's College School Wimbledon, where they completed 3 A-Levels and obtained 13 GCSEs, but the exact years are not provided in the information.